Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from FDA

Review: The FDA's Awful Labeling Regulations Made the Baby Formula Shortage Worse

Elaborate labeling requirements blocked the importation of direly needed European baby formula.

Reason

A Quick Breakdown Of The Right To Contraception Act

In the wake of Dobbs, the Democratic-controlled House is passing a flurry of bills to "codify" constitutional rights that are not really in jeopardy. Yesterday, I wrote about the Respect For Marriage Act, which would require a state to recognize same-sex marriages performed in another state. This bill passed with…

Reason

House approves measure to protect the right to contraception

WASHINGTON — The House on Thursday passed legislation that would codify the federal right to contraception, although the measure faces slim odds in the Senate because of GOP concerns about the broadness of the bill.

Tribune News Service

From analysis to the latest developments in health,
read the most diverse news in one place.

Chuck Schumer's Doomed Marijuana Monstrosity Is Not a Serious Attempt To Repeal Pot Prohibition

The Senate majority leader's 296-page bill would compound the barriers to successful legalization.

Reason

What to know about Paxlovid, the COVID drug President Biden is using to speed recovery

Paxlovid has been highly effective at reducing the risks of hospitalization and death, but some patients report a "Paxlovid rebound," in which the disease returns.

WEKU

How Donald Trump’s fight with Covid unfolded two years before Biden diagnosis

Low blood oxygen levels and lung issues led officials to believe Trump might have to be put on ventilator in 2020

The Independent UK

SPRC: Clinical-stage pharma company using cannabinoids to address serious health issues.

By Brad Sorensen, CFA NASDAQ:SPRC

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Skittles lawsuit: What is titanium dioxide and why is Mars being sued?

Titanium dioxide is a colour additive known more commonly as E171.

Evening Standard

Daily Biotech Pulse: Liver Disease-Focused Gene Therapy Pact, Assembly Bio Stops HBV Infection Trial, X4 Pharma Looks For Partners

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

House seeks to protect contraception after Roe changes - Roll Call

Eight Republicans crossed the aisle to join every House Democrat on a bill that would codify the federal right to contraception.

Roll Call

TikTok’s ‘Pink Sauce’ Is Appalling The Internet When Did We Stray So Far From The Path Of God

It's the EZ Squirt of our generation.

Pedestrian.tv

Food expiration dates don't have much science behind them – a food safety researcher explains another way to know what's too old to eat

Florida’s outbreak of listeria has so far led to at least one death, 22 hospitalizations and an ice cream recall since January. Humans get sick with listeria infections, or listeriosis, from eating soil-contaminated food, undercooked meat or dairy products that are raw, or unpasteurized. Listeria can cause convulsions, coma, miscarriage…

The Conversation

Why Baker Hughes Shares Dropped 8%; Here Are 64 Biggest Movers From Yesterday

Gainers Pagaya Technologies Ltd. (NASDAQ: PGY) shares climbed 129.6% to close at $6.20 on Wednesday. Pagaya Technologies is expected to announce its Q2 earnings on August 16, 2022.

Benzinga

Clinics now allowed to purchase, prescribe antiviral drugs

The Food and Drug Administration has given the green light for clinics to purchase and prescribe molnupiravir and other antiviral drugs for Covid-19 patients.

Bangkok Post

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Recap of Wednesday's Biotech Catalysts - End of The Day Summary

Salon

Experts still torn on throat swabbing

Other countries' health bureaus have advised the public to throat-swab when taking at-home tests, but not the US

Chicago Tribune

Abbott reports strong earnings despite infant formula crisis

Abbott Laboratories reported strong earnings Wednesday, despite spending recent months responding to criticism over problems that led to the shutdown of one of its infant formula-producing plants.

The Independent UK

How canine heart disease was tied to grain-free dog food

In 2018, the FDA began investigating whether the increasing popularity of grain-free dog foods had led to a sudden rise in a potentially fatal heart disease in dogs

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

The Daily Biotech Pulse: CDC AdComm Backs Novavax COVID-19 Vaccine, European Approval For PTC Therapeutics' Gene Therapy, Merck's Keytruda Flunks In Head, Neck Cancer Study

Here's a roundup of top developments in the biotech space over the last 24 hours:

Chicago Sun-Times

Get fourth COVID booster now, or wait? CDC says get the shot now, but many hesitate

About 70% of Americans 50 and older who got a first booster shot — and nearly as many of those 65 and older — haven’t gotten their second booster dose, the CDC says.

Salon

Skittles "unfit" for humans: lawsuit

When Americans eat Skittles, are they tasting more than just the rainbow?

Benzinga

Recap of Tuesday's Biotech Catalysts - End Of The Day Summary

The U.S. Food and Drug Administration (FDA) has granted tentative approval to Avadel Pharmaceuticals’ (NASDAQ: AVDL) lead candidate LUMRYZ (FT218) for the treatment of excessive daytime sleepiness (EDS) or cataplexy in adults with narcolepsy.

The Independent UK

FDA weighs oversight changes after Juul, formula troubles

The head of the Food and Drug Administration is commissioning an independent review of the agency’s food and tobacco programs

StockNews.com

Is Novavax a Buy, Sell, or Hold Following FDA Decision?

Despite the FDA authorization of Novavax’s (NVAX) two-dose vaccine, the possible side effects and slow vaccine uptake keep the stock under pressure. So, let’s evaluate if it is worth adding the stock to one’s portfolio now. Read on….

Benzinga

The Daily Biotech Pulse: FDA Tentatively Approves Avadel's Narcolepsy Drug, European Approval Broadens AstraZeneca's Enhertu in Breast Cancer, Pharma Giants' Earnings

Here's a roundup of top developments in the biotech space over the last 24 hours:

1 … 197 198 199 200

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Public Health Ministry

436 stories

Hill

419 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.